ASBISc Enterprises Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

ASBISc Enterprises heeft een totaal eigen vermogen van $280.6M en een totale schuld van $238.9M, wat de schuld-eigenvermogensverhouding op 85.2% brengt. De totale activa en totale passiva bedragen respectievelijk $885.9M en $605.3M. De EBIT ASBISc Enterprises is $102.2M waardoor de rentedekking 4 is. Het heeft contanten en kortetermijnbeleggingen van $58.9M.

Belangrijke informatie

85.2%

Verhouding schuld/eigen vermogen

US$238.94m

Schuld

Rente dekkingsratio	4x
Contant	US$58.93m
Aandelen	US$280.58m
Totaal verplichtingen	US$605.34m
Totaal activa	US$885.92m

Recente financiële gezondheidsupdates

Recent updates

ASBISc Enterprises Plc's (WSE:ASB) CEO Compensation Is Looking A Bit Stretched At The Moment

May 02

Is ASBISc Enterprises (WSE:ASB) A Risky Investment?

Dec 01

Is There Now An Opportunity In ASBISc Enterprises Plc (WSE:ASB)?

Sep 02

Here's Why We Think ASBISc Enterprises (WSE:ASB) Is Well Worth Watching

May 05

Does ASBISc Enterprises (WSE:ASB) Have A Healthy Balance Sheet?

Apr 06

Do ASBISc Enterprises's (WSE:ASB) Earnings Warrant Your Attention?

Jan 19

We Think ASBISc Enterprises (WSE:ASB) Can Stay On Top Of Its Debt

Oct 23

We Think ASBISc Enterprises (WSE:ASB) Can Stay On Top Of Its Debt

Apr 29

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $800.1M ) ASB } overtreffen de korte termijn passiva ( $575.5M ).

Langlopende schulden: De kortetermijnactiva ASB ( $800.1M ) overtreffen de langetermijnschulden ( $29.9M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 64.2% ) ASB wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van ASB is de afgelopen 5 jaar gedaald van 134.8% naar 85.2%.

Schuldendekking: De schuld van ASB wordt niet goed gedekt door de operationele kasstroom ( 8.3% ).

Rentedekking: De rentebetalingen op de schuld van ASB worden goed gedekt door EBIT ( 4 x dekking).

ASBISc Enterprises Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is ASBISc Enterprises (WSE:ASB) A Risky Investment?

Does ASBISc Enterprises (WSE:ASB) Have A Healthy Balance Sheet?

We Think ASBISc Enterprises (WSE:ASB) Can Stay On Top Of Its Debt

We Think ASBISc Enterprises (WSE:ASB) Can Stay On Top Of Its Debt

Recent updates

New major risk - Financial position

Second quarter 2024 earnings released: EPS: US$0.11 (vs US$0.20 in 2Q 2023)

Now 24% overvalued

Upcoming dividend of US$0.30 per share

Asbis Provides Earnings Guidance for the Year 2024

New minor risk - Financial position

First quarter 2024 earnings released: EPS: US$0.25 (vs US$0.31 in 1Q 2023)

Asbis to Pay Additional Dividend from Profit for 2023, Payable on June 27, 2024

Now 22% overvalued

ASBISc Enterprises Plc to Report First Half, 2024 Results on Aug 08, 2024

ASBISc Enterprises Plc's (WSE:ASB) CEO Compensation Is Looking A Bit Stretched At The Moment

Final dividend of US$0.30 announced

ASBISc Enterprises Plc, Annual General Meeting, May 08, 2024

Full year 2023 earnings released: EPS: US$0.96 (vs US$1.37 in FY 2022)

ASBISc Enterprises Plc Recommends Dividend for the Year 2023

Full year 2023 earnings released: EPS: US$0.96 (vs US$1.37 in FY 2022)

Asbis Enterprises Plc Provides Earnings Guidance for the Year 2023

ASBISc Enterprises Plc to Report Q1, 2024 Results on May 31, 2024

Asbis Provides Consolidated Revenues Guidance for the Month of October 2023

Upcoming dividend of US$0.20 per share at 6.6% yield

Third quarter 2023 earnings released

Second quarter 2023 earnings released: EPS: US$0.20 (vs US$0.20 in 2Q 2022)

Now 21% undervalued

Upcoming dividend of US$0.25 per share at 6.5% yield

Now 23% undervalued

First quarter 2023 earnings released: EPS: US$0.31 (vs US$0.24 in 1Q 2022)

Full year 2022 earnings released: EPS: US$1.37 (vs US$1.39 in FY 2021)

Now 21% undervalued

Full year 2022 earnings released: EPS: US$1.37 (vs US$1.39 in FY 2021)

ASBISc Enterprises Plc Provides Revenue Guidance for the Full Year 2023

ASBIS Provides Revenue Guidance for the Month of December 2022

ASBISc Enterprises Plc to Report Fiscal Year 2022 Results on Mar 30, 2023

ASBISc Enterprises Plc Provides Consolidated Earnings Guidance for the Month of November 2022

ASBISc Enterprises Plc Revises Earnings Guidance for the Year 2022

Is ASBISc Enterprises (WSE:ASB) A Risky Investment?

ASBISc Enterprises Plc Provides Consolidated Revenues Guidance for the Month of October 2022

Less than half of directors are independent

ASBISc Enterprises Plc (WSE:ASB) agreed to acquire 16% of Promed Bioscience Ltd for €0.8 million.

Upcoming dividend of US$0.20 per share

Third quarter 2022 earnings released: EPS: US$0.36 (vs US$0.33 in 3Q 2021)

ASBISc Enterprises Plc (WSE:ASB) acquired 20% stake in Displayforce Global Ltd.

ASBISc Enterprises Plc Announces Interim Dividend from the Company's Profit for 2022, Payable on December 1St, 2022

ASBISc Enterprises Plc Provides Consolidated Revenues Guidance for the Month of September 2022

Investor sentiment improved over the past week

ASBISc Enterprises Plc Provides Consolidated Revenue Guidance for August 2022

Is There Now An Opportunity In ASBISc Enterprises Plc (WSE:ASB)?

ASBISc Enterprises Plc Announces consolidated revenue Guidance for July 2022

ASBISc Enterprises Plc Provides Earnings Guidance for 2022

Second quarter 2022 earnings released: EPS: US$0.20 (vs US$0.27 in 2Q 2021)

Asbisc Enterprises plc Provides Consolidated Revenue Guidance for the Month of June 2022

Asbisc Enterprises plc Provides Consolidated Revenue Guidance for the Month of May 2022

First quarter 2022 earnings released: EPS: US$0.29 (vs US$0.27 in 1Q 2021)

Upcoming dividend of US$0.10 per share

ASBISc Enterprises Plc Declares Dividend for 2021, Payable on May 26, 2022

Here's Why We Think ASBISc Enterprises (WSE:ASB) Is Well Worth Watching

Less than half of directors are independent

ASBISc Enterprises Plc Provides Consolidated Revenue Guidance for March 2022

ASBISc Enterprises Plc, Annual General Meeting, May 04, 2022

Full year 2021 earnings released: EPS: US$1.39 (vs US$0.66 in FY 2020)

ASBISc Enterprises Plc (WSE:ASB) commences an Equity Buyback Plan for 2,000,000 shares, for a total of $1 million, under the authorization approved on March 28, 2022.

Does ASBISc Enterprises (WSE:ASB) Have A Healthy Balance Sheet?

ASBISc Enterprises Plc Board of Directors Recommends on the Final Dividend for 2021

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

ASBISc Enterprises plc Provides Revenue Guidance for January 2022

ASBISc Enterprises Plc Provides Consolidated Revenue Guidance for the Month of December 2021

Investor sentiment deteriorated over the past week

Do ASBISc Enterprises's (WSE:ASB) Earnings Warrant Your Attention?

ASBISc Enterprises plc Provides Revenue Guidance for the Month of November 2021

ASBISc Enterprises Plc (WSE:ASB) acquired 20% stake in EMBIO Diagnostics Ltd for €1 million.

ASBISc Enterprises Plc Provides Revenue Guidance for the Month October 2021